An argument for permitting amphetamines and instant-release methylphenidate.
作者信息
Flanigan Jessica
机构信息
University of Richmond, Leadership Studies and PPEL, Richmond, VA 23173, USA.
出版信息
Am J Bioeth. 2013;13(7):49-51. doi: 10.1080/15265161.2013.794884.
PMID:23767443
Abstract
摘要
相似文献
1
An argument for permitting amphetamines and instant-release methylphenidate.关于允许使用苯丙胺和速释哌醋甲酯的一种观点。
Am J Bioeth. 2013;13(7):49-51. doi: 10.1080/15265161.2013.794884.
2
Moving beyond methylphenidate and amphetamine: the ethics of a better "smart drug".超越哌醋甲酯和苯丙胺：一种更好的“聪明药”的伦理问题。
Am J Bioeth. 2013;13(7):43-5. doi: 10.1080/15265161.2013.794881.
3
Regulating methylphenidate: enhancing cognition and social inequality.管控哌甲酯：提升认知与加剧社会不平等
Am J Bioeth. 2013;13(7):47-9. doi: 10.1080/15265161.2013.794886.
4
Enhancement policy and the value of information.增强策略与信息价值
Am J Bioeth. 2013;13(7):34-5. doi: 10.1080/15265161.2013.795826.
5
Response to open peer commentaries on "prohibition or coffee shops: regulation of amphetamine and methylphenidate for enhancement use by healthy adults".对关于“禁止或开设咖啡店：对健康成年人用于增强目的的苯丙胺和哌醋甲酯的管制”的公开同行评论的回应
Am J Bioeth. 2014;14(1):W1-8. doi: 10.1080/15265161.2014.862417.
6
There may be costs to failing to enhance, as well as to enhancing.不进行强化以及进行强化都可能会有成本。
Am J Bioeth. 2013;13(7):38-9. doi: 10.1080/15265161.2013.796222.
7
The indirect psychological costs of cognitive enhancement.认知增强的间接心理成本。
Am J Bioeth. 2013;13(7):45-7. doi: 10.1080/15265161.2013.794880.
8
How research on stakeholder perspectives can inform policy on cognitive enhancement.关于利益相关者观点的研究如何为认知增强政策提供信息。
Am J Bioeth. 2013;13(7):41-3. doi: 10.1080/15265161.2013.794882.
9
A liberal consequentialist approach to regulation of cognitive enhancers.一种关于认知增强剂监管的自由主义后果主义方法。
Am J Bioeth. 2013;13(7):53-5. doi: 10.1080/15265161.2013.796220.
10
Tobacco: prohibition, coffee shops, or discouragement?烟草：禁止、开设咖啡店还是加以劝阻？
Am J Bioeth. 2013;13(7):51-3. doi: 10.1080/15265161.2013.796022.
Zotero 插件